Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.
Summary
- On April 30, 2025, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 155 restricted stock units vested, converting into 155 shares of common stock.
- Following the transaction, Krognes directly owns 10,837 shares of common stock and 2,160 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects insider activity related to compensation.
Key Dates
| Date | Description |
|---|---|
| August 9, 2022 | Date of grant for the restricted stock unit award. |
| June 30, 2023 | Date when 25% of the restricted stock units vested. |
| April 30, 2025 | Date of the reported transaction where restricted stock units vested and converted to common stock. |
| May 01, 2025 | Date of signature for the form. |
Keywords
Form 4, Guardant Health, Stock Transaction, Director, Steve Krognes, Restricted Stock Units, Common Stock, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.